This article is educational and does not replace medical advice. Prescription medication requires review by a licensed clinician and, when appropriate, a valid prescription. Compounded medications are not FDA-approved, and the FDA does not verify their safety, effectiveness or quality before marketing. Treatment eligibility is an individual clinical decision.

Written by Dr. Parmis Mojarab, DO·Reviewed by Jonathan Snipes, MD·Published July 12, 2026·Last reviewed July 12, 2026·Methodology v1.0

503A vs 503B compounding pharmacies

Quick answer

503A pharmacies compound patient-specific prescriptions; 503B outsourcing facilities register with the FDA and can produce larger batches under stricter quality standards. Neither makes an FDA-approved product, but 503B carries more federal oversight.

503A pharmacies

Traditional compounding pharmacies preparing patient-specific prescriptions under state board oversight. They do not require FDA registration as outsourcing facilities.

503B outsourcing facilities

Register with the FDA, follow current good manufacturing practice (cGMP) standards, and can compound larger batches. More federal oversight, but still not producing FDA-approved finished drugs.

Why it matters for patients

A named, verifiable pharmacy — and knowing whether it is 503A or 503B — is a core legitimacy check. Programs that will not name their pharmacy fail this test.

Frequently asked questions

Is 503B safer than 503A?

503B facilities follow stricter federal manufacturing standards and more oversight, but neither pathway produces an FDA-approved drug. Both can be legitimate when properly licensed.

Sources

U.S. Food and Drug Administration — labels and safety communications.
Peer-reviewed clinical trials cited above.
Our methodology and medical review policy.

Spotted an error? Submit a correction.